Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential induction chemoradiotherapy followed by surgery for locally advanced thymic tumors
ChiCTR-OIC-16009130Phase 2Recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Aug 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and carboplatin in Thymic neoplasm, sponsored by Shanghai Chest Hospital. Primary endpoint: response rate. Started Aug 2015; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Thymic neoplasm
Beyond the preview
Go deeper on ChiCTR-OIC-16009130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-16009130.